Effectiveness of Whole, Inactivated, Low Pathogenicity Influenza A(H7N9) Vaccine against Antigenically Distinct, Highly Pathogenic H7N9 Virus.
Emerg Infect Dis
; 24(10): 1910-1913, 2018 10.
Article
en En
| MEDLINE
| ID: mdl-30226171
ABSTRACT
The recent emergence of highly pathogenic influenza A(H7N9) variants poses a great risk to humans. We show that ferrets vaccinated with low pathogenicity H7N9 virus vaccine do not develop severe symptoms after infection with an antigenically distinct, highly pathogenic H7N9 virus. These results demonstrate the protective benefits of this H7N9 vaccine.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Vacunas contra la Influenza
/
Vacunas de Productos Inactivados
/
Gripe Humana
/
Subtipo H7N9 del Virus de la Influenza A
/
Antígenos Virales
Límite:
Animals
/
Female
/
Humans
Idioma:
En
Año:
2018
Tipo del documento:
Article